CN106661588B - 双顺反子细菌表达系统 - Google Patents

双顺反子细菌表达系统 Download PDF

Info

Publication number
CN106661588B
CN106661588B CN201580037078.3A CN201580037078A CN106661588B CN 106661588 B CN106661588 B CN 106661588B CN 201580037078 A CN201580037078 A CN 201580037078A CN 106661588 B CN106661588 B CN 106661588B
Authority
CN
China
Prior art keywords
cistron
antibody
inclusion bodies
ranibizumab
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201580037078.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN106661588A (zh
Inventor
沙尔顿尔·萨卢西
布拉杰什·瓦尔什尼
萨德希巴布·索拉帕内尼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lupin Ltd
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Publication of CN106661588A publication Critical patent/CN106661588A/zh
Application granted granted Critical
Publication of CN106661588B publication Critical patent/CN106661588B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H6/00—Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
    • A01H6/34—Cucurbitaceae, e.g. bitter melon, cucumber or watermelon 
    • A01H6/342—Citrullus lanatus [watermelon]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/27—Erwinia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24029—Aureolysin (3.4.24.29)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/515—Complete light chain, i.e. VL + CL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Botany (AREA)
  • Physiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN201580037078.3A 2014-07-09 2015-07-09 双顺反子细菌表达系统 Expired - Fee Related CN106661588B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2245MU2014 2014-07-09
IN2245/MUM/2014 2014-07-09
PCT/IB2015/055189 WO2016005931A1 (en) 2014-07-09 2015-07-09 Dual cistronic bacterial expression system

Publications (2)

Publication Number Publication Date
CN106661588A CN106661588A (zh) 2017-05-10
CN106661588B true CN106661588B (zh) 2020-11-06

Family

ID=53773474

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580037078.3A Expired - Fee Related CN106661588B (zh) 2014-07-09 2015-07-09 双顺反子细菌表达系统

Country Status (20)

Country Link
US (2) US10329571B2 (enExample)
EP (1) EP3167065B1 (enExample)
JP (1) JP6748061B2 (enExample)
CN (1) CN106661588B (enExample)
AU (1) AU2015287296A1 (enExample)
BR (1) BR112017000389A2 (enExample)
CA (1) CA2954594A1 (enExample)
CY (1) CY1123303T1 (enExample)
DK (1) DK3167065T3 (enExample)
ES (1) ES2808906T3 (enExample)
HR (1) HRP20200996T1 (enExample)
HU (1) HUE050300T2 (enExample)
LT (1) LT3167065T (enExample)
MX (1) MX378585B (enExample)
PH (1) PH12017500047A1 (enExample)
PL (1) PL3167065T3 (enExample)
PT (1) PT3167065T (enExample)
RU (1) RU2732148C2 (enExample)
SI (1) SI3167065T1 (enExample)
WO (1) WO2016005931A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6435770B2 (ja) * 2014-01-21 2018-12-12 東ソー株式会社 シグナルペプチドをコードするポリヌクレオチドおよびそれを用いたタンパク質の製造方法
WO2017021819A1 (en) * 2015-07-31 2017-02-09 Dr. Reddy’S Laboratories Limited Process for preparation of protein or peptide
KR102607655B1 (ko) 2017-05-19 2023-11-28 카운슬 오브 사이언티픽 앤드 인더스트리얼 리서치 리폴딩된 재조합 인간화 라니비주맙의 제조 방법
ES2965485T3 (es) * 2017-08-23 2024-04-15 Novartis Ag Sistema de expresión de proteínas con múltiples copias génicas
CN113631567B (zh) * 2018-07-06 2025-02-07 瓦克化学股份公司 在发酵方法中释放重组蛋白的细菌菌株
JP7762935B2 (ja) * 2019-01-31 2025-10-31 Ｓｐｉｂｅｒ株式会社 組換え細胞、発現構築物、及び組換えタンパク質の製造方法
KR20210148288A (ko) * 2019-04-02 2021-12-07 카운슬 오브 사이언티픽 앤드 인더스트리얼 리서치 생체내 리폴딩된 항체 단편의 클로닝 및 발현
CN114774453B (zh) * 2022-03-14 2023-04-21 湖北大学 一种运动发酵单胞菌基因表达严谨调控系统的构建方法和应用
CN116334118A (zh) * 2023-02-23 2023-06-27 四川大学 一种原核体系中单启动子控制多个颗粒蛋白亚基组装同源等同体在胞内恒定比例表达并共自组装的方法
CN118995554B (zh) * 2024-09-09 2025-07-04 江南大学 一种大肠杆菌整合表达体系及其在酶高效表达中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003018771A2 (en) * 2001-08-27 2003-03-06 Genentech, Inc. A system for antibody expression and assembly

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7018809B1 (en) 1991-09-19 2006-03-28 Genentech, Inc. Expression of functional antibody fragments
JP4309656B2 (ja) 2000-12-14 2009-08-05 ジェネンテック・インコーポレーテッド 原核生物で生成させた抗体とその用途
DK2046382T3 (en) * 2006-07-10 2016-12-12 Esbatech Alcon Biomed Res Unit scFv Antibodies which passes through the epithelial and / or endothelial layer
RU2413769C1 (ru) * 2009-12-24 2011-03-10 Учреждение Российской академии наук Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pET-32a, КОДИРУЮЩАЯ ГЕН ЛИГАНД-СВЯЗЫВАЮЩЕГО ДОМЕНА РЕЦЕПТОРА II ТИПА ТРАНСФОРМИРУЮЩЕГО ФАКТОРА РОСТА-β ЧЕЛОВЕКА (TβRII), ШТАММ БАКТЕРИЙ Escherichia coli - ПРОДУЦЕНТ СЛИТНОГО БЕЛКА ТИОРЕДОКСИН/TβRII И СПОСОБ РЕНАТУРАЦИИ И ОЧИСТКИ ЦЕЛЕВОГО БЕЛКА TβRII
GB201002730D0 (en) * 2010-02-18 2010-04-07 Uni I Oslo Product
US8853380B2 (en) 2010-06-04 2014-10-07 Lupin Limited Modified SAK gene for the production of recombinant proteins
CA2904146C (en) * 2013-03-08 2023-03-21 Neuclone Biologics Pty Ltd A cell expression system
CA2911087A1 (en) * 2013-04-30 2014-11-06 Harish Shandilya Novel cloning, expression & purification method for the preparation of ranibizumab
TW201534726A (zh) * 2013-07-03 2015-09-16 Halozyme Inc 熱穩定ｐｈ２０玻尿酸酶變異體及其用途

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003018771A2 (en) * 2001-08-27 2003-03-06 Genentech, Inc. A system for antibody expression and assembly

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Over-expression of proteins using a modified pBAD24 vector in E. coli expression system;Sampali Banerjee等;《Biotechnol Lett》;20090329;第31卷;第1031-1036页 *
The Presence of N-Terminal Secretion Signal Sequences Leads to Strong Stimulation of the Total Expression Levels of Three Tested Medically Important Proteins during High-Cell-Density Cultivations of Escherichia coli;H. Sletta等;《APPLIED AND ENVIRONMENTAL MICROBIOLOGY》;20061201;第73卷(第3期);第906-912页 *
Two-promoter vector is highly efficient for overproduction of protein complexes;KYUNG-JIN KIM等;《Protein Science》;20041231;第13卷;第1698-1703页 *

Also Published As

Publication number Publication date
CY1123303T1 (el) 2021-12-31
EP3167065B1 (en) 2020-03-25
US20190309313A1 (en) 2019-10-10
ES2808906T3 (es) 2021-03-02
CA2954594A1 (en) 2016-01-14
AU2015287296A1 (en) 2017-02-02
WO2016005931A1 (en) 2016-01-14
HRP20200996T1 (hr) 2021-01-08
US11365418B2 (en) 2022-06-21
US20170159060A1 (en) 2017-06-08
BR112017000389A2 (pt) 2018-01-23
US10329571B2 (en) 2019-06-25
DK3167065T3 (da) 2020-07-06
PL3167065T3 (pl) 2020-11-16
CN106661588A (zh) 2017-05-10
EP3167065A1 (en) 2017-05-17
SI3167065T1 (sl) 2020-09-30
HUE050300T2 (hu) 2020-11-30
JP2017520261A (ja) 2017-07-27
PT3167065T (pt) 2020-07-01
LT3167065T (lt) 2020-07-27
RU2732148C2 (ru) 2020-09-11
MX2017000332A (es) 2017-07-28
MX378585B (es) 2025-03-10
PH12017500047A1 (en) 2017-05-22
JP6748061B2 (ja) 2020-08-26

Similar Documents

Publication Publication Date Title
CN106661588B (zh) 双顺反子细菌表达系统
US20220213500A1 (en) Expression Process
US10113193B2 (en) Method for optimizing the assembly and production of hetero-multimeric protein complexes
ES2792350T3 (es) Secuencia señal secretora de organismos eucariotas para la expresión recombinante en organismos procariotas
US10465220B2 (en) Expression process
HK1246822B (zh) 双顺反子细菌表达系统
HK1246822A1 (zh) 双顺反子细菌表达系统
CN110636859A (zh) 用于产生重折叠的重组人源化兰尼单抗的方法
KR20230044256A (ko) Il-5의 결합 분자 및 그 제조 방법과 응용
JP5733693B2 (ja) 組換え型ポリペプチドの製造方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1246822

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20201106

Termination date: 20210709

CF01 Termination of patent right due to non-payment of annual fee